摘要 |
The present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the formula (I) wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP> and R<SUP>8</SUP> are each independently a member selected from the group consisting of H, C<SUB>1-6</SUB> alkyl and OH; R<SUP>4</SUP>, R<SUP>7</SUP> and R<SUP>9</SUP> are each independently selected from the group consisting of C<SUB>1-6</SUB> alkoxy and OH; R<SUP>10</SUP> is a member selected from the group consisting of H, -OH, -OP(O)Me<SUB>2</SUB>, (II) -O-(CH<SUB>2</SUB>)<SUB>n</SUB>-OH and -O-(CH<SUB>2</SUB>)<SUB>m</SUB>-O-(CH<SUB>2</SUB>)<SUB>o</SUB>- CH<SUB>3</SUB>, wherein subscripts n and m are each independently from 2 to 8 and subscript o is from 1 to 6; each of L<SUP>1</SUP> and L<SUP>4</SUP> are independently selected from the group consisting of: (III) each of L and L3 are independently selected from the group consisting of: (IV) salts, hydrates, isomers, metabolites and prodrugs thereof. |
申请人 |
ELIXIR MEDICAL CORPORATION;YAN, JOHN;ZHENG, XIAOXIA;BHAT, VINAYAK D. |
发明人 |
YAN, JOHN;ZHENG, XIAOXIA;BHAT, VINAYAK D. |